Study of Patients With Non-Small Cell Lung Cancer, Esophageal Cancer, Malignant Pleural Mesothelioma, Mediastinal or Chest Wall Neoplasms, or Lung Metastases From Cancers of Non-Thoracic Origin
This study is currently recruiting patients.
| Sponsored by: | National Cancer Institute (NCI) |
| Information provided: | National Cancer Institute (NCI) |
| ClinicalTrials.gov Identifier: | NCT00447447 |
Purpose:
RATIONALE: Collecting and storing samples of tissue, blood, and urine from patients with cancer to study in the laboratory may help the study of cancer. It may also help doctors identify patients who are eligible for clinical trials.
PURPOSE: This study is collecting and examining tissue, blood, and urine samples from patients with non-small cell lung cancer, esophageal cancer, malignant pleural mesothelioma, mediastinal or chest wall neoplasms, or lung metastases from cancers of non-thoracic origin.
| Condition | Intervention | Phase |
|
Esophageal Cancer Lung Cancer Malignant Mesothelioma Mediastinal Cancer Metastatic Cancer Thymoma and Thymic Carcinoma |
Genetic: DNA methylation analysis Genetic: gene expression analysis Procedure: bronchoscopy Procedure: diagnostic thoracoscopy Procedure: endoscopic biopsy Procedure: fine-needle aspiration Procedure: needle biopsy |
N/A |
Eligibility
Study Design: Primary Purpose: Diagnostic
Official Title: Prospective Evaluation of Epigenetic Alterations in Patients With Lung and Esophageal Cancers and Malignant Pleural Mesotheliomas
Enrollment Size: Both
Gender: N/A
Min. Age: N/A
Max. Age: No
Location and Contact Information
United States, Maryland
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office, Bethesda, Maryland, 20892-1182, United States
Status: Recruiting
Clinical Trials Office - Warren Grant Magnusen Clinical Center 888-NCI-1937
Last modified: July 29 2010.
